Log on / register
Feedback | Support | My details

Pre-publication history

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

Anthony Gonçalves* email, Séverine Esteyries* email, Brynn Taylor-Smedra email, Arnaud Lagarde email, Mounay Ayadi email, Geneviève Monges email, François Bertucci email, Benjamin Esterni email, Jean-Robert Delpero email, Olivier Turrini email, Bernard Lelong email, Patrice Viens email, Jean-Paul Borg email, Daniel Birnbaum email, Sylviane Olschwang email and Frédéric Viret email

BMC Cancer 2008, 8:169doi:10.1186/1471-2407-8-169

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript21 Oct 2007
Reviewer's ReportAlberto Bardelli09 Dec 2007
Reviewer's ReportStuart Schwartz14 Dec 2007
Resubmission - Version 2ManuscriptAuthors' comments05 Feb 2008
Resubmission - Version 3ManuscriptAuthors' comments05 Feb 2008
Reviewer's ReportAlberto Bardelli13 Mar 2008
Reviewer's ReportFrederic Waldman09 May 2008
Resubmission - Version 4ManuscriptAuthors' comments11 May 2008
Resubmission - Version 5ManuscriptAuthors' comments11 May 2008
Resubmission - Version 6ManuscriptAuthors' comments16 May 2008
Resubmission - Version 7Manuscript20 May 2008
Resubmission - Version 8Manuscript20 May 2008
Resubmission - Version 9ManuscriptAuthors' comments25 May 2008
Resubmission - Version 10Manuscript29 May 2008
Accepted10 Jun 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.